NCT02171468View on ClinicalTrials.gov

Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule in Healthy Japanese and Caucasian Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 31, 2006

Conditions
Healthy
Interventions
DRUG

Dabigatran high dose

DRUG

Dabigatran low dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY